Quality of life in primary sclerosing cholangitis: a systematic review

[1] Karlsen TH(2017)Primary sclerosing cholangitis—a comprehensive review J Hepatol 67 1298-1323

[2] Folseraas T(2016)Primary sclerosing cholangitis N Engl J Med 375 1161-1170

[3] Thorburn D(2012)Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease Inflamm Bowel Dis 18 2270-2276

[4] Vesterhus M(2013)Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis Hepatology 58 2045-2055

[5] Lazaridis KN(2015)ACG clinical guideline: primary sclerosing cholangitis Am J Gastroenterol 110 646-659

[6] LaRusso NF(2019)British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis Gut 68 1356-1378

[7] Boonstra K(2017)Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis Gastroenterology 152 1975-1984

[8] van Erpecum KJ(2018)Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists Clin Gastroenterol Hepatol 16 278-87e7

[9] van Nieuwkerk KMJ(2015)A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease Aliment Pharmacol Ther 41 980-990

[10] Drenth JPH(2017)Primary sclerosing cholangitis and the management of uncertainty and complexity Frontline Gastroenterol 8 260-266

[1] Karlsen TH(2017)Primary sclerosing cholangitis—a comprehensive review J Hepatol 67 1298-1323

[2] Folseraas T(2016)Primary sclerosing cholangitis N Engl J Med 375 1161-1170

[3] Thorburn D(2012)Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease Inflamm Bowel Dis 18 2270-2276

[4] Vesterhus M(2013)Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis Hepatology 58 2045-2055

[5] Lazaridis KN(2015)ACG clinical guideline: primary sclerosing cholangitis Am J Gastroenterol 110 646-659

[6] LaRusso NF(2019)British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis Gut 68 1356-1378

[7] Boonstra K(2017)Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis Gastroenterology 152 1975-1984

[8] van Erpecum KJ(2018)Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists Clin Gastroenterol Hepatol 16 278-87e7

[9] van Nieuwkerk KMJ(2015)A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease Aliment Pharmacol Ther 41 980-990

[10] Drenth JPH(2017)Primary sclerosing cholangitis and the management of uncertainty and complexity Frontline Gastroenterol 8 260-266